Skip to main content
. 2017 Sep 7;20(2):184–191. doi: 10.1093/neuonc/nox175

Fig. 1.

Fig. 1

Illustration of key components of the BBB that provide physical (tight and adherens junctions) and biochemical (transporter-mediated efflux) barriers to brain penetration of antiglioma agents.